Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Immune Abnormalities in Sporadic Inclusion Body Myositis

This study has been completed.
Sponsor:
Information provided by:
National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier:
NCT00030212
First received: February 7, 2002
Last updated: March 5, 2008
Last verified: December 2007